6505-01-314-2716 Omeprazole extended-release caps
One item DLA buys: its open requests for quotation, approved sources and past DLA awards.
Overview
National Stock Number record
- Open RFQs
- 2
- Next due November 17, 2026
- Last price paid
- …
- Standard price
- $82.00 per BT
- DLA's catalog price, not a price paid
- Approved sources
- 4
- Awards on record
- 182
- 2013 to 2026
- DLA demand
- –
Identification
- Item name
- Omeprazole extended-release caps
- FSC / PSC
- 6505 · Drugs and biologicals
- NSG (group)
- 65 · Medical/dental/veterinary eqpt/supp
- NIIN assigned
- 27-JAN-90
- Unit
- BT
- NSN
- 6505-01-314-2716
- NIIN
- 01-314-2716
Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
Approved suppliers
Manufacturers and part numbers DLA has qualified for this item, and the part numbers in its catalog record
| Supplier | CAGE | CAGE status | Part status (RNCC / RNVC) | Supplier part # | Listed in |
|---|---|---|---|---|---|
| SANDOZ INC. | 0THL4 | A (Active) | 5 (Secondary reference) / 2 (An item-identifying number) | NDC00781-2868-31 | DLA approved-source file |
| ASTRA PHARMACEUTICAL PRODUCTS INC | 1AK01 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC00186-0742-31 | DLA approved-source file |
| GOLDEN STATE MEDICAL SUPPLY, INC. | 1HT23 | A (Active) | 5 (Secondary reference) / 2 (An item-identifying number) | NDC60505-0065-00 | DLA approved-source file |
| AMERISOURCE HEALTH SERVICES, LLC | 71M28 | A (Active) | 5 (Secondary reference) / 2 (An item-identifying number) | NDC51407-0813-30 | DLA approved-source file |
| 4LQT5 | A (Active) | 3 (Design control reference) / 1 (Not identify an item of production without the use of additional information) | NDC00186-0742-31 | FLIS part list | |
| 1GAU9 | H (Obsolete entity has been discontinued) | 5 (Secondary reference) / 9 (Was the design control reference) | NDC00186-0742-31 | FLIS part list |
Source: DLA's approved-source file published with the RFQs and the part list of DLA's catalog record (FLIS). CAGE and part status are FLIS's codes with DLA's wording.
Pricing and awardees
Supply contracts
3 contracts DLA ordered this item under
| Award ID | Awardee | Awarding office | Ceiling | Ordering ends | Type | Multiple award | Orders | Last order |
|---|---|---|---|---|---|---|---|---|
| SPE2DX25D9900 | DMS PHARMACEUTICAL GROUP INC | SPE2DX | $19,999,999 | March 6, 2038 | INDEFINITE DELIVERY / REQUIREMENTS | No | 14 | July 24, 2026 |
| SPE2DX15D0022 | CARDINAL HEALTH, INC. | SPE2DX | $20,000,000 | June 30, 2025 | INDEFINITE DELIVERY / INDEFINITE QUANTITY | No | 3 | August 20, 2018 |
| SPM2D008D0252 | DIXON-SHANE, LLC | SPM2D0 | $5,780,512 | December 11, 2018 | INDEFINITE DELIVERY / INDEFINITE QUANTITY | No | 1 | March 9, 2018 |
Source: DLA's procurement history files (the contract each order was placed under), the item's newest 2,000 award lines, joined to FPDS by the contract number. Multiple award, ordering period and ceiling are FPDS's; DLA's files do not give them.
Characteristics
Government-defined characteristics of this item (FLIS)
Hazardous and environmental
- Hazardous material (HMIC)
- P (No information in hmirs)
Additional identifiers
- II
- 0
- DEMIL
- A: No demilitarization required
- Precious metals (PMIC)
- A (Does not contain precious metal)
- Schedule B
- 3004909260 (Medicaments primarily affect digest system nesoi)
- PINC
- 0042777
- Criticality (CRIT CD)
- X
- On FedMall
- Yes
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
Major organizational entity (MOE) rules
How each service or agency buys and manages this item
| Rule | MOE | AMC | AMSC | NIMSC | IMC | AAC | DSOR |
|---|---|---|---|---|---|---|---|
| A911 | Army (DA) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| FSGM | Air Force (DF) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| MC55 | Marine Corps (DM) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| N9BL | Navy (DN) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| VE01 | Oman (VE) | ||||||
| VP01 | Peru (VP) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.
Government organizations
The services and agencies that manage or use this item
| Organization | Effective date | Unit of issue | Unit price | Qty per unit | Controlled inventory | Shelf life | Acquisition advice | Source of supply |
|---|---|---|---|---|---|---|---|---|
| Army (DA) | 01-OCT-2025 | BT | $57.86 | 1 (1) | U (Unclassified) | K (18 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Air Force (DF) | 01-OCT-2025 | BT | $57.86 | 1 (1) | U (Unclassified) | K (18 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Marine Corps (DM) | 01-OCT-2025 | BT | $57.86 | 1 (1) | U (Unclassified) | K (18 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Navy (DN) | 01-OCT-2025 | BT | $57.86 | 1 (1) | U (Unclassified) | K (18 months) | L (Local purchase) | SMS (Defense logistics agency) |
| DLA (DS) | 01-OCT-2026 | BT | $82.00 | 1 (1) | U (Unclassified) | K (18 months) | L (Local purchase) | SMS (Defense logistics agency) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.
DIBBS RFQs
Recent DLA requests for quotation for this item on DIBBS, newest first: 2 open now
| Solicitation | NSN | Item name | Qty | Unit | Std. price | Last price | Est. value | Set-aside | Tech docs | Posted | Return by |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPE2DP27T0346DIBBS only | 6505-01-314-2716 | Omeprazole extended-release caps | 2 | BT | $82.00 per BT | … | … | No set-aside | No | November 12, 2026 | November 18, 20264 days left |
| SPE2DP27T0286DIBBS only | 6505-01-314-2716 | Omeprazole extended-release caps | 8 | BT | $82.00 per BT | … | … | No set-aside | No | November 11, 2026 | November 17, 20263 days left |
| SPE2DP27Q0003DIBBS only | 6505-01-314-2716 | Omeprazole extended-release caps | 8 | BT | $82.00 per BT | … | … | No set-aside | No | October 19, 2026 | October 22, 2026Closed |
→ These RFQs in the DIBBS list
Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
DLA award history
182 award lines since 2013, 5 winning CAGEs
| Winner | Awards | Last award |
|---|---|---|
| 00E55Cardinal Health, Inc. | 117 | June 6, 2024 |
| 1UNB0DMS PHARMACEUTICAL GROUP INC | 50 | July 24, 2026 |
| 0AG09SZY HOLDINGS, LLC | 7 | November 5, 2026 |
| 5J522DIXON-SHANE LLC | 6 | March 9, 2018 |
| 3W8H0MR UNLIMITED, LLC | 2 | August 18, 2025 |
| Year | Awards | Winning CAGEs |
|---|---|---|
| 2026 | 19 | 2 |
| 2025 | 30 | 2 |
| 2024 | 1 | 1 |
| 2022 | 6 | 2 |
| 2021 | 2 | 2 |
| 2020 | 3 | 2 |
| 2019 | 2 | 2 |
| 2018 | 4 | 2 |
| 2017 | 7 | 3 |
| 2016 | 7 | 3 |
| 2015 | 8 | 2 |
| 2014 | 51 | 2 |
| 2013 | 42 | 2 |
Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.
DLA awards for this item
25 awards from the item's award history, in FPDS
| Rank | Vendor | Obligated | |
|---|---|---|---|
| 1 | DMS PHARMACEUTICAL GROUP INC | $193,538 | 50 |
| 2 | MR UNLIMITED, LLC | $738 | 2 |
| 3 | CARDINAL HEALTH, INC. | $356 | 30 |
| 4 | SZY HOLDINGS, LLC | $115 | 3 |
| 5 | DIXON-SHANE, LLC | $19 | 5 |
| Contract | Awarded | Awardee | Obligated |
|---|---|---|---|
| SPE2DP26F8088From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $174 |
| SPE2DP26F8097From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $436 |
| SPE2DP26F8217From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $436 |
| SPE2DP26F8218From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $349 |
| SPE2DP26F8219From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $174 |
| SPE2DP26F8220From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $3,924 |
| SPE2DP26F8222From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $131 |
| SPE2DP26F8223From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $131 |
| SPE2DP26F8224From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $131 |
| SPE2DP26F8227From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $87 |
| SPE2DP26F8236From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $1,134 |
| SPE2DP26F8244From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $305 |
| SPE2DP26F8265From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $131 |
| SPE2DP26F8274From the item's award history | July 24, 2026 | DMS PHARMACEUTICAL GROUP INC | $1,177 |
| SPE2DP26P0605From the item's award history | March 18, 2026 | SZY HOLDINGS, LLC | $56 |
| SPE2DP26F1348From the item's award history | December 17, 2025 | DMS PHARMACEUTICAL GROUP INC | $0 |
| SPE2DP26F0928From the item's award history | November 26, 2025 | DMS PHARMACEUTICAL GROUP INC | $0 |
| SPE2DP26F0359From the item's award history | October 16, 2025 | DMS PHARMACEUTICAL GROUP INC | $87 |
| SPE2DP26F0116From the item's award history | October 2, 2025 | DMS PHARMACEUTICAL GROUP INC | $218 |
| SPE2DP25F146EFrom the item's award history | September 27, 2025 | DMS PHARMACEUTICAL GROUP INC | $218 |
| SPE2DP25F133WFrom the item's award history | September 22, 2025 | DMS PHARMACEUTICAL GROUP INC | $44 |
| SPE2DP25F127QFrom the item's award history | September 17, 2025 | DMS PHARMACEUTICAL GROUP INC | $87 |
| SPE2DP25F128FFrom the item's award history | September 17, 2025 | DMS PHARMACEUTICAL GROUP INC | $1,003 |
| SPE2DP25F096GFrom the item's award history | September 3, 2025 | DMS PHARMACEUTICAL GROUP INC | $87 |
| SPE2DP25F082ZFrom the item's award history | August 25, 2025 | DMS PHARMACEUTICAL GROUP INC | $44 |
Showing 1 to 10 of 25 results
Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.